RenovoRx, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 3.26 million compared to USD 3 million a year ago. Basic loss per share from continuing operations was USD 0.36 compared to USD 0.33 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | +6.61% |
|
+5.22% | -47.16% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.16% | 27.19M | |
+18.43% | 122B | |
+19.81% | 112B | |
-23.74% | 19.33B | |
-18.45% | 16.17B | |
-19.97% | 15.6B | |
-49.33% | 14.65B | |
+57.08% | 14.34B | |
+7.95% | 14B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- RNXT Stock
- News RenovoRx, Inc.
- RenovoRx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023